Avita Medical (RCEL) vs Shoulder Innovations (SI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Avita Medical (RCEL) has outperformed Shoulder Innovations (SI) over the past year, gaining 138.6% versus a gain of 42.8%. Avita Medical is the larger company by market cap ($412.3 million vs $372.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RCEL | SI |
|---|---|---|
| Share price | $13.33 | $17.89 |
| Market cap | $412.25M | $372.45M |
| 1-day change | +2.15% | -4.38% |
| YTD return | +278.26% | +30.84% |
| 1-year return | +138.57% | +42.82% |
| 5-year return | -24.87% | — |
| P/E ratio (TTM) | — | 22.09 |
| EPS (TTM) | $-1.43 | $0.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.50 | $24.60 |
| 52-week low | $3.22 | $10.92 |
| Distance from 52-week high | -1.26% | -27.26% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | -9.75% | +46.73% |
| Average volume | 441.70K | 116.50K |
| Shares outstanding | 30.93M | 20.82M |
| Employees | 226 | — |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RCEL has outperformed SI by 95.7 percentage points over the past year.
About Avita Medical
RCEL stock →AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions.
Health Care · Medical/Dental Instruments · 226 employees
RCEL vs SI FAQ
Which is bigger, Avita Medical or Shoulder Innovations?
Avita Medical (RCEL) is larger, with a market capitalization of $412.25M compared with $372.45M for Shoulder Innovations (SI).
Which stock has performed better over the past year, RCEL or SI?
RCEL returned +138.57% over the past 12 months, compared with +42.82% for SI (price return, excluding dividends). Past performance does not predict future results.
Are Avita Medical and Shoulder Innovations in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.